{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:40:47Z","timestamp":1787902847990,"version":"build-2784847793"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.omtm.2023.08.013","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T21:34:21Z","timestamp":1693863261000},"page":"500-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"30","author":[{"given":"Harry","family":"Wilton-Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7316-3546","authenticated-orcid":false,"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2023.08.013_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne Muscular Dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.omtm.2023.08.013_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.omtm.2023.07.004","article-title":"Prevention of Early-Onset Cardiomyopathy in Dmd Exon 52\u201354 Deletion Mice by CRISPR-Cas9-Mediated Exon Skipping","volume":"30","author":"Rok","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.08.013_bib3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/d41573-023-00103-y","article-title":"FDA Grants Accelerated Approval to First Gene Therapy for Duchenne Muscular Dystrophy, despite Internal Objections","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2023.08.013_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112546119","article-title":"Development of DG9 Peptide-Conjugated Single- and Multi-Exon Skipping Therapies for the Treatment of Duchenne Muscular Dystrophy","volume":"119","author":"Lim","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.08.013_bib5","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1212\/WNL.0000000000006950","article-title":"Cardiac and Skeletal Muscle Effects in the Randomized HOPE-Duchenne Trial","volume":"92","author":"Taylor","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2023.08.013_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ymthe.2019.01.005","article-title":"RAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging Mdx Mouse Heart","volume":"27","author":"Xu","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.08.013_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(22)00012-5","article-title":"Repeated Intravenous Cardiosphere-Derived Cell Therapy in Late-Stage Duchenne Muscular Dystrophy (HOPE-2): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial","volume":"399","author":"McDonald","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2023.08.013_bib9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1177\/0192623317734823","article-title":"Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical Endpoints, and Biomarker Quantification","volume":"45","author":"Wilson","year":"2017","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omtm.2023.08.013_bib10","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.045369","article-title":"A Novel\u00a0Mouse Model of Duchenne Muscular Dystrophy Carrying a Multi-Exonic DMD Deletion Exhibits Progressive Muscular Dystrophy and Early-Onset Cardiomyopathy","volume":"13","author":"Wong","year":"2020","journal-title":"Dis. Model. Mech."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T01:37:59Z","timestamp":1714786679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050123001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":9,"alternative-id":["S2329050123001274"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2023.08.013","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2023.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}